CDMOs race to add capacity as cell and gene therapy demand outpaces supply
DDDr. Dereck Mush, MD, MBA
Jan 14Conference
Advanced Therapies USA
America's main cell and gene therapy congress, covering development, manufacturing, evidence and market access.
- When
- November, November 4 to 5, 2026
- Where
- Boston, USAView on Google Maps
- Format
- In person
- Organiser
- Terrapinn
- Region
- North America
- Scale
- About 1,200 attendees
The Signal
The Advanced Therapies Congress USA gathers roughly 1,200 executives at the Hynes Convention Center in Boston across two days, with about 200 speakers and 50 start-ups. Content spans twelve tracks covering cell therapy, gene therapy, gene editing, regenerative medicine, manufacturing, supply chain, pricing and market access. Attendees include pharma and biotech leaders, researchers, clinicians, payers and regulators.
What to expect
- Keynotes on the gene therapy development journey
- Panels on market success for cell and gene therapy
- Investment outlook for advanced therapies
- Manufacturing and supply chain strategy sessions
Who is in the room
Cell and gene therapy executives, manufacturing and regulatory leads, investors, clinicians and payers.
Related events
Running this event, or spotted something out of date?
Related reading
Beyond the Genetic Ceiling: How Scholar Rock's FDA Approval for Isembyld Unlocks the Muscle-Directed Neuromuscular Economy
DDDr. Dereck Mush, MD, MBA
Sep 14
Beyond PD-L1: How the I3LUNG Consortium Validated Multimodal AI in 2,365 Advanced Lung Cancer Patients
DDDr. Dereck Mush, MD, MBA
Sep 15
A CDMO partnership shows how gene therapy manufacturing is scaling for chronic disease
DDDr. Dereck Mush, MD, MBA
Sep 3Keep exploring